These data also suggest that the mechanistic basis for the genetic associations between the PTER locus and BMI in humans may involve N-acetyltaurine. In the future, the development of potent and selective PTER inhibitors may enable pharmacological targeting of this biochemical pathway for the treatment of obesity. Here, PTER is linked to obesity due to melanocortin 4 receptor deficiency.